TB/HIV Brochure

International Meeting on HIV/TB Research and Networking

WHO and the TB/HIV Working Group of the Stop TB Partnership in collaboration with the International AIDS Society, the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), Treatment Action Group and the Desmond Tutu HIV Center are organizing a highly visible meeting on HIV/TB research issues in conjunction with the upcoming 5th IAS Conference on HIV pathogenesis, treatment and prevention. The meeting will be held on July 18 (afternoon) and July 19 (morning), 2009 in Cape Town, South Africa.

The meeting will bring notable researchers and leaders in the areas of TB prevention, childhood TB/HIV, TB treatment and diagnosis, and the interaction between HIV and drug resistant TB. it is also intended to create a forum to exchange ongoing research activities, including data among researchers.

The meeting will also inform the revision of the WHO HIV/TB research priorities. The meeting will be held in the Desmond Tutu HIV Center, University of Cape Town on July 18-19, 2009, prior to the opening of the 5th international conference on HIV pathogenesis treatment and prevention conference.

Deadline for registration: registration should be submitted no later than June 15, 2009 by emailing Ms Rosalie Edma at: edmar@who.int mention "HIV/TB research meeting" in the subject line.

TB/HIV at CROI 2009

The Stop TB Department of WHO in collaboration with the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) organized a meeting affiliated with the 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009) in Montreal, Canada. This is the third in a series of meetings organized since 2007.

The meetings have successfully raised the profile of HIV/TB among HIV researchers in particular by sharing data from ongoing studies, identifying research gaps and stimulating further HIV/TB research. The main objective of the meeting at CROI 2009 was to promote high level scientific interchange of ideas and research priorities to have a better understanding of the magnitude and burden of TB (including drug resistant strains) especially in HIV prevalent settings.

Read the presentations made at the meeting

PK and Drug Interactions in a Changing World: New Drugs for TB and New Regimens for TB-HIV Co-infection by Charles Flexner, MD, Johns Hopkins University

Treatment of Extensively Drug Resistant Tuberculosis Among Patients with HIV Infection in South Africa by Max O’Donnell , Nesri Padayatchi, Iqubal Master, Garth Osburn, Robert Horsburgh

Sensitivity, specificity and predictive values of symptoms to detect tuberculosis in the ZAMSTAR community based prevalence studies by Peter Godfrey-Faussett and Helen Ayles, London School of Hygiene and Tropical Medicine, UK

• If you have TB/HIV Operational research study results you would like to share please tell us about it in one paragraph. Contact us at: tbhiv@who.int
  
  
• CREATE - Read more